Table 4.
Author (yr) | AST (U/L) | AST (U/L) | AST (U/L) | ALT (U/L) | ALT (U/L) | ALT (U/L) |
Day 1 | Day 3 | Day 7 | Day 1 | Day 3 | Day 7 | |
THO/HHO | THO/HHO | THO/HHO | THO/HHO | THO/HHO | THO/HHO | |
Wu et al (2002) | 420 ± 790/290 ± 770 | 180 ± 320/190 ± 510 | 50 ± 40/30 ± 20 | 370 ± 490/480 ± 510 | 330 ± 320/320 ± 270 | 90 ± 20/70 ± 20 |
Yuan et al (2010) | 812.6 ± 475.3/447.6 ±210.3 | 423.7 ± 265.4/207.5 ± 79.3 | 143.6 ± 87.5/64.2 ± 29.4 | 1013.6 ± 654.4/369.4 ± 347.2 | 592.2 ± 416.4/218.4 ± 185.3 | 172.4 ± 125.8/ 79.6 ± 55.3 |
Figueras et al (2005) | NS | NS | NS | 402 ± 258/372 ± 234 | NS | NS |
THO: Total hepatic inflow occlusion; HHO: Hemihepatic vascular occlusion.